drugset / Trial / NCT04503733
A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension
RandomizedSequentialDouble-blindTreatment
Summary
A Randomized, Placebo-Controlled, Double-blind, Dose Escalation Study to Assess Safety, Efficacy and Pharmacokinetics of GMA301 Injection in Subjects with Pulmonary Arterial Hypertension
Timeline
- Start
- 2020-10-22
- Primary completion
- 2022-10-26
- Completion
- 2023-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PATECIBART | Monoclonal antibody | 300 mg | Intravenous |
| Subject | PATECIBART | Monoclonal antibody | 600 mg | Intravenous |
| Subject | PATECIBART | Monoclonal antibody | 1000 mg | Intravenous |
| Subject | PATECIBART | Monoclonal antibody | 1800 mg | Intravenous |